Gastrointestinal Cancer News

A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and screening people with tumors associated with multiple endocrine neoplasia type 1.

SAN DIEGO — Screening rates for colorectal cancers were doubled, CRC-related mortality cut in half and racial disparities nearly eliminated with a 20-year outreach program, according to study results presented at Digestive Disease Week.

Smoking status added to the National Cancer Database for patients diagnosed with cancer in 2023 revealed variations in sociodemographic and socioeconomic factors, according to a research letter in JAMA Oncology.

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their confirmatory trials demonstrated meaningful clinical benefits, according to results of a retrospective study.

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic gastrointestinal cancers than prior strategies, according to results of a phase 2 trial.

Patients with advanced cancer should be enrolled in early phase clinical trials during favorable points in their disease rather than after exhausting standard-of-care treatments, according to a paper published in JCO Oncology Practice.

The American Society for Radiation Oncology has issued its first clinical guideline on the use of radiation therapy to treat adults with anal cancer.

Cancer mortality gradually declined over the past 2-plus decades, although the rate slowed between 2019 and 2022, according to results of the Annual Report to the Nation on the Status of Cancer.

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance intended to improve the design of randomized phase 3 trials.